首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 (2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-咪唑-5-基)甲基)-53-氨基-14,23,44-三(4-氨基丁基)-8,20,41-三苄基-50-((S)-仲丁基)-32-(羟甲基)-38-异丁基-5-异丙基-11,29-二甲基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-十七酮基-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十七氮杂五十三烷酰胺基)-5-(4-氨基丁基)-11-((S)-仲丁基)-2-(羟甲基)-8-(2-(甲硫基)乙基)-4,7,10,13-四酮基-3,6,9,12-四氮杂十七烷二酸

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-咪唑-5-基)甲基)-53-氨基-14,23,44-三(4-氨基丁基)-8,20,41-三苄基-50-((S)-仲丁基)-32-(羟甲基)-38-异丁基-5-异丙基-11,29-二甲基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-十七酮基-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十七氮杂五十三烷酰胺基)-5-(4-氨基丁基)-11-((S)-仲丁基)-2-(羟甲基)-8-(2-(甲硫基)乙基)-4,7,10,13-四酮基-3,6,9,12-四氮杂十七烷二酸

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-imidazol-5-yl)methyl)-53-amino-14,23,44-tris(4-aminobutyl)-8,20,41-tribenzyl-50-((S)-sec-butyl)-32-(hydroxymethyl)-38-isobutyl-5-isopropyl-11,29-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-heptadecaazatripentacontanamido)-5-(4-aminobutyl)-11-((S)-sec-butyl)-2-(hydroxymethyl)-8-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaheptadecanedioic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

108433-99-4

中文名称

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-咪唑-5-基)甲基)-53-氨基-14,23,44-三(4-氨基丁基)-8,20,41-三苄基-50-((S)-仲丁基)-32-(羟甲基)-38-异丁基-5-异丙基-11,29-二甲基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-十七酮基-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十七氮杂五十三烷酰胺基)-5-(4-氨基丁基)-11-((S)-仲丁基)-2-(羟甲基)-8-(2-(甲硫基)乙基)-4,7,10,13-四酮基-3,6,9,12-四氮杂十七烷二酸

英文名称

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-imidazol-5-yl)methyl)-53-amino-14,23,44-tris(4-aminobutyl)-8,20,41-tribenzyl-50-((S)-sec-butyl)-32-(hydroxymethyl)-38-isobutyl-5-isopropyl-11,29-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-heptadecaazatripentacontanamido)-5-(4-aminobutyl)-11-((S)-sec-butyl)-2-(hydroxymethyl)-8-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaheptadecanedioic acid

别名

Magainin 1 (Xenopus petersii);Magainin I peptide;Magainina 1;Magainin 1 peptide, Xenopus;MAGAININ 1;MAGAININ I;GLY-ILE-GLY-LYS-PHE-LEU-HIS-SER-ALA-GLY-LYS-PHE-GLY-LYS-ALA-PHE-VAL-GLY-GLU-ILE-MET-LYS-SER;GIGKFLHSAGKFGKAFVGEIMKS

标准英文名

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-imidazol-5-yl)methyl)-53-amino-14,23,44-tris(4-aminobutyl)-8,20,41-tribenzyl-50-((S)-sec-butyl)-32-(hydroxymethyl)-38-isobutyl-5-isopropyl-11,29-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-heptadecaazatripentacontanamido)-5-(4-aminobutyl)-11-((S)-sec-butyl)-2-(hydroxymethyl)-8-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaheptadecanedioic acid

MDL No.

MFCD00133521

分子式

C112H177N29O28S

分子量

2409.89

精确分子量

2408.30

SMILES

CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C

标准SMILES

CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O

用途

Magainin 1 exhibits antimicrobial activity against a broad spectrum of Gram-negative and Gram-positive bacteria; it has potential applications as an antibiotic agent due to its ability to interact with acidic lipids via electrostatic and hydrophobic interactions, forming an amphipathic helix that induces membrane leakage, particularly of calcein from negatively charged vesicles.

InChIKey

OFIZOVDANLLTQD-ZVNXOKPXSA-N

安全信息

SureRoute逆合成路线

1.  108433-99-4 逆合成路线 1

—
—
ACTUMS616
108433-99-4
来源: SureRoute

2.  108433-99-4 逆合成路线 2

—
—
ACTUMS616
108433-99-4
来源: SureRoute

3.  108433-99-4 逆合成路线 3

—
—
ACTUMS616
108433-99-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手